Aiolos Bio
3 known investors
Aiolos Bio is a biopharma company that discovers, develops, and delivers medicines and vaccines across respiratory, immunology, inflammation, oncology, HIV, and infectious diseases.
Investors Β· 3
Companies House Β· registry record
View on Companies House β- Registered name
- AIOLOS BIO LIMITED
- Company number
- 14956089
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 23 Jun 2023
- Registered office
- 79 New Oxford Street, London, WC1A 1DG
- Nature of business (SIC)
- 72110 β Research and experimental development on biotechnology
- Previous names
- ONE BIOTECH LIMITED (2023β2023)
- Accounts
- last made up to 31 Dec 2024 Β· next due 30 Sept 2026
- Confirmation statement
- last made up to 16 Apr 2026 Β· next due 30 Apr 2027
Current officers Β· 2
- Peter Kenneth Hopkins β director, appointed 14 Feb 2024
- Edinburgh Pharmaceutical Industries Limited β corporate director, appointed 14 Feb 2024
Source: Companies House public register Β· retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Aiolos Bio do?
- Aiolos Bio is a biopharma company that discovers, develops, and delivers medicines and vaccines across respiratory, immunology, inflammation, oncology, HIV, and infectious diseases.
- Who are Aiolos Bio's investors?
- Aiolos Bio's investors include Bain Capital Life Sciences, RA Capital, Sofinnova Ventures.